New Wave Holdings Appoints Daniel Fox as CEO & Diego Gianelli as Director


Ryan Allway

September 17th, 2020

Psychedelics


NEW WAVE HOLDINGS CORP. (the “Company” or “New Wave Holdings“) (CSE: SPOR) (Frankfurt: 0XM2) (OTC: TRMND), an investment issuer focused on emerging sectors including the psychedelic sector, is pleased to announce the appointment of Daniel Fox as Chief Executive Officer (“CEO”) and Diego Gianelli to the Board of Directors.

The board of directors is very pleased to announce that Daniel Fox has been appointed CEO. Clayton Fisher interim CEO and Director has tendered his resignation as interim CEO and is also stepping down from his role as Director. The Board would like to thank Clayton for his service and contributions to the Company.

About Daniel Fox

Daniel is a business Leader, Board Member, CMO, President & CEO with global experience, who elevates performance through contagious energy and drive. Daniel’s proven ability to develop differentiating strategy and build teams that can execute along with a strong reputation for embracing difficult business challenges makes him an exceptional leader. Daniel prides on being a team player that is willing to think outside the box and collaborate with all members of the team.

Daniel is highly adaptable with diverse experience across a range of industries including beverage alcohol, pharmaceutical technology, pre-engineered building manufacturing and cannabis related CBD product development. Daniel’s established work experience in these various industries allows him to bring a robust network and rolodex that will bring value to any enterprise regardless of size or stage.

Daniel brings large corporate and smaller fast paced entrepreneurial and public company experience with a proven track record of success in all business situations e.g. start-up, driving organic growth, business turnaround, restructuring, joint ventures, acquisitions, strategy development and new product / brand innovation. Daniel played a pivotal role in Sleeman Breweries’ launch of various products that are considered best-selling brands today and were all brands and formulations constructed by Daniel during his tenure at Sleeman as a Managing Director.  Daniel’s ability to innovate and deliver results in enterprise growth with ventures of all sizes and stages brings tremendous value and credibility with a track record of execution.

Daniel’s educational background includes a BBA from Simon Fraser University and an MBA from Athabasca University.

About Diego Gianelli

Diego is an accomplished business leader with +20 years of progressive global leadership experience in building some of the world’s most iconic consumer brands and delivering strong financial results.  Diego is an innovator, agile operator and servant leader with exceptional analytical skills and business acumen, having led complex business transformations in order to reinvigorate stagnant categories, turn-around declining businesses and start up new ventures in high growth environments in pharmaceutical, food and beverages, and QSR.

Most recently, Diego played a pivotal role in building the consumer business fundamentals and laying out the strategic groundwork for companies entering the nascent Cannabis space. He unlocked multiple digital/CRM strategies to target, convert and retain high value lifetime customers across every stage of the path-to-purchase funnelling while complying with a highly regulated marketing framework. At Aurora, Diego led the creation and refinement of a superior portfolio of consumer brands and products, growing profitable sales and achieving #1 market share position in both Adult-Use and Medical markets in Canada and Europe. At Auxly, Diego was tasked to build a multi-channel product platform, supply chain, commercial partnerships and go-to-market strategies. Under his leadership, the company unlocked high-margin downstream distribution channels, designed and built out licensed retail stores, led consumer insights work and innovation roadmaps to bring 2.0 derivate products to market.

Previously, Diego held several marketing, sales and general management positions at Tim Hortons and Starbucks, heading up their packaged good operations/retail strategy in US and Canada and building in-market capabilities and global partnerships that resulted in record double digit EBITDA and category sales growth. At Tim Hortons, Diego rapidly outpaced established US competitors by expanding geographic distribution in both existing and new markets. During his tenure at Starbucks, Diego led the planning and launch of the two most successful product innovations in the company’s history (VIA and Blond Roast) and developed first-to-market Omni-channel marketing strategies that unlocked consumer engagement and economic efficiencies across digital, wholesale/food service and retail stores. Previously at Kraft and Nestle, Diego led cross-functional teams that revitalized stagnant brands in declining categories through successful brand repositioning; breakthrough innovation, digital campaigns and consumer inspired merchandising solutions.

Diego holds an MBA, from Rotman School of Management and has been an active board member in national industry associations, such as the FCPC and non-profit charitable organizations.

“We are pleased to share the appointment of Daniel and Diego. Both are specialist in consumer-packaged goods which a key area that the Company will benefit from. Daniel will lead the team in the development and marketing of our functional mushroom products, and I believe that Daniel is the right person to lead New Wave into the future. said Trumbull Fisher, President of New Wave Holdings.

ABOUT NEW WAVE HOLDINGS CORP.

New Wave Holdings Corp. (CSE: SPOR, FWB: 0XM2, OTC:TRMND) is an investment issuer focused on the burgeoning psychedelic and esports sectors. In the psychedelic sector, New Wave will focus on supporting research on active psychedelic compounds, creation of consumer products based on functional mushrooms, and developing an IP portfolio focusing on psilocybin, LSD, MDMA, and ketamine derived treatments for neuropsychiatric diseases.

Investors interested in connecting with New Wave Holdings can learn more about the company and contact the team at http://newwavecorp.com

Media interested in interviews and more information may contact Brittany Whitmore at brittany@exvera.com.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading